Pomer S - Search Results

1

Complement activation in renal allograft recipients.

Kirschfink M, Wienert T, Rother K, Pomer S. Kirschfink M, et al. Among authors: pomer s. Transplant Proc. 1992 Dec;24(6):2556-7. Transplant Proc. 1992. PMID: 1465864 No abstract available.

2

[The effect of the complement system on the acute reversible rejection of kidney transplants].

Kirschfink M, Wienert T, A Prado EB, Pomer S. Kirschfink M, et al. Among authors: pomer s. Immun Infekt. 1995 Apr;23(2):55-6. Immun Infekt. 1995. PMID: 7744427 German.

3

[Significance of the complement system for xenotransplantation: strategies for therapeutic intervention].

Kirschfink M, Haferkamp A, Pomer S, Chrupcala M, Wosnik A, Heckl-Ostreicher B. Kirschfink M, et al. Among authors: pomer s. Zentralbl Chir. 1998;123(7):793-7. Zentralbl Chir. 1998. PMID: 9746977 Review. German.

4

In vitro B cell response in long-term renal transplant recipients.

Weimer R, Zipperle S, Daniel V, Pomer S, Staehler G, Opelz G. Weimer R, et al. Among authors: pomer s. Transplant Proc. 1992 Dec;24(6):2537-8. Transplant Proc. 1992. PMID: 1465858 No abstract available.

5

Non-complement-fixing antibodies as indicators for impending renal allograft rejection.

Daniel V, Berteli AJ, Röhl L, Pomer S, Opelz G. Daniel V, et al. Among authors: pomer s. Transplant Proc. 1989 Feb;21(1 Pt 1):702-3. Transplant Proc. 1989. PMID: 2650231 No abstract available.

6

Plasma GM-CSF, IL-6, and IL-3 monitoring allows differentiation between infection and rejection in some renal transplant recipients: preliminary results of a retrospective study.

Daniel V, Pasker S, Reiss U, Weimer R, Wiesel M, Pomer S, Staehler G, Opelz G. Daniel V, et al. Among authors: pomer s. Transplant Proc. 1993 Feb;25(1 Pt 2):893-6. Transplant Proc. 1993. PMID: 8382882 No abstract available.

7

Cytokine monitoring of infection and rejection in renal transplant recipients.

Daniel V, Pasker S, Wiesel M, Carl S, Pomer S, Staehler G, Schnobel R, Weimer R, Opelz G. Daniel V, et al. Among authors: pomer s. Transplant Proc. 1995 Feb;27(1):884-6. Transplant Proc. 1995. PMID: 7879219 No abstract available.

8

Preliminary evidence that monitoring of plasma granulocyte-macrophage colony-stimulating factor may be helpful to differentiate between infection and rejection in renal transplant patients.

Daniel V, Pasker S, Reiss U, Weimer R, Pomer S, Staehler G, Opelz G. Daniel V, et al. Among authors: pomer s. Transplant Proc. 1992 Dec;24(6):2770-2. Transplant Proc. 1992. PMID: 1334598 No abstract available.

9

Prospective trial of OKT3 for early prophylaxis of rejection in immunologic "high risk" renal transplant recipients: long-term results.

Pomer S, Waldherr R, Möhring K, Kempter F, Wiesel M, Weimer R. Pomer S, et al. Transplant Proc. 1992 Oct;24(5):1732-3. Transplant Proc. 1992. PMID: 1412815 Clinical Trial. No abstract available.

10

IL-6 independent monocyte/B cell defect in renal transplant recipients with long-term stable graft function.

Weimer R, Zipperle S, Daniel V, Pomer S, Staehler G, Opelz G. Weimer R, et al. Among authors: pomer s. Transplantation. 1994 Jan;57(1):54-9. doi: 10.1097/00007890-199401000-00011. Transplantation. 1994. PMID: 7507271

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

78 results

Search Page

Filters